DMK Pharmaceuticals Statistics
Important Dates
| Earnings Date | n/a | 
| Ex-Dividend Date | n/a | 
Share Statistics
DMKPQ has 10.09 million shares outstanding.
| Current Share Class | 10.09M | 
| Shares Outstanding | 10.09M | 
| Shares Change (YoY) | n/a | 
| Shares Change (QoQ) | +174.99% | 
| Owned by Insiders (%) | n/a | 
| Owned by Institutions (%) | 0.00% | 
| Float | n/a | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| PB Ratio | n/a | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | n/a | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
The company has a current ratio of 0.58
| Current Ratio | 0.58 | 
| Quick Ratio | 0.50 | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | -0.01 | 
| Interest Coverage | -127.25 | 
Financial Efficiency
| Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | -102.41% | 
| Return on Invested Capital (ROIC) | n/a | 
| Return on Capital Employed (ROCE) | 383.62% | 
| Revenue Per Employee | 301,641 | 
| Profits Per Employee | -1.87M | 
| Employee Count | 12 | 
| Asset Turnover | 0.34 | 
| Inventory Turnover | 5.66 | 
Taxes
In the past 12 months, DMKPQ has paid 2,000 in taxes.
| Income Tax | 2,000 | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
| Beta (5Y) | 32.15 | 
| 52-Week Price Change | n/a | 
| 50-Day Moving Average | 0.00 | 
| 200-Day Moving Average | n/a | 
| Relative Strength Index (RSI) | 36.14 | 
| Average Volume (20 Days) | 3,160 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | 0.13 | 
Income Statement
In the last 12 months, DMKPQ had revenue of 3.62 million and -22.41 million in losses. Loss per share was -6.39.
| Revenue | 3.62M | 
| Gross Profit | -1.35M | 
| Operating Income | -17.28M | 
| Pretax Income | -21.16M | 
| Net Income | -22.41M | 
| EBITDA | -16.65M | 
| EBIT | -17.28M | 
| Loss Per Share | -6.39 | 
Balance Sheet
The company has 6.66 million in cash and 63,209 in debt, giving a net cash position of 6.60 million or 0.65 per share.
| Cash & Cash Equivalents | 6.66M | 
| Total Debt | 63,209 | 
| Net Cash | 6.60M | 
| Net Cash Per Share | 0.65 | 
| Equity (Book Value) | -4.96M | 
| Book Value Per Share | -0.52 | 
| Working Capital | -5.59M | 
Cash Flow
In the last 12 months, operating cash flow was -9.38 million and capital expenditures -91,494, giving a free cash flow of -9.47 million.
| Operating Cash Flow | -9.38M | 
| Capital Expenditures | -91,494 | 
| Free Cash Flow | -9.47M | 
| FCF Per Share | -0.94 | 
Margins
| Gross Margin | -37.30% | 
| Operating Margin | -477.45% | 
| Pretax Margin | -584.45% | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
DMKPQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -63.90% | 
| Shareholder Yield | -63.90% | 
| Earnings Yield | -224,053,080.00% | 
| FCF Yield | -94,746,130.00% | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
The last stock split was on May 22, 2023. It was a reverse split with a ratio of 0.0142857.
| Last Split Date | May 22, 2023 | 
| Split Type | Reverse | 
| Split Ratio | 0.0142857 | 
Scores
DMKPQ has an Altman Z-Score of -56.52 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -56.52 | 
| Piotroski F-Score | 3 |